Isidro Palos

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies

Isidro Palos, Edgar E. Lara‐Ramírez, Julio Cesar López-Cedillo et al. · Molecules · 2017 · 54 citations · Full text

Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives

Juan Carlos Villalobos‐Rocha, Luvia Enid Sánchez‐Torres, Benjamín Nogueda‐Torres et al. · Parasitology Research · 2014 · 43 citations

Anti-trypanosoma Cruzi, Parasitic Protozoa, Medicine +4

The effect of relative humidity on tensile strength and water vapor permeability in chitosan, fish gelatin and transglutaminase edible films

Sofia Alvarado, Glória SANDOVAL, Isidro Palos et al. · Food Science and Technology · 2015 · 39 citations · Full text

Food Chemistry, Materials Science, Mixed Biopolymers +14

Old Antiprotozoal Drugs: Still viable Options for Parasitic Diseases or New Options for Other Diseases?

Sandra Cortez-Maya, Antonio Moreno-Herrera, Isidro Palos et al. · Current Medicinal Chemistry · 1969 · 23 citations

Parasitic Disease, Viable Options, Antiparasitic Agent +13

Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from Entamoeba histolytica and Giardia lamblia Identifies Inhibitors of Their Trophozoite Growth Phase

Alfredo Juárez-Saldívar, Elizabeth Barbosa, Edgar E. Lara‐Ramírez et al. · International Journal of Molecular Sciences · 2021 · 19 citations · Full text